How Techcyte’s Fusion Platform is Shaping the Future of Digital Pathology and AI Integration

At USCAP 2025, Techcyte’s Chief Medical Officer, Dr. Tiffany Chen, and CEO, Ben Cahoon, joined Dr. Aleks Zuraw of Digital Pathology Place to celebrate the launch of Fusion AP. They discussed how Fusion streamlines case management, enhances diagnostic accuracy, and integrates AI into everyday pathology workflows. The conversation also covered the importance of open standards, Techcyte’s partnerships, and the critical role of flexible integration in driving healthcare innovation.